{"id":1083,"date":"2019-08-16T06:50:45","date_gmt":"2019-08-16T06:50:45","guid":{"rendered":"https:\/\/credevo.com\/s\/?page_id=1083"},"modified":"2023-08-04T17:14:37","modified_gmt":"2023-08-04T09:14:37","slug":"rare-diseases-regulatory-service","status":"publish","type":"page","link":"https:\/\/credevo.com\/s\/rare-diseases-regulatory-service\/","title":{"rendered":"Regulatory Services"},"content":{"rendered":"\n<h2 class=\"has-text-align-center wp-block-heading\">Is regulatory for orphan drugs in rare diseases different from traditional drugs?<\/h2>\n\n\n\n<div style=\"height:20px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<div class=\"wp-block-media-text alignwide has-media-on-the-right is-stacked-on-mobile\"><figure class=\"wp-block-media-text__media\"><img loading=\"lazy\" decoding=\"async\" width=\"1024\" height=\"548\" src=\"https:\/\/credevo.com\/s\/wp-content\/uploads\/2020\/03\/rarediseaseregulatory_orphandrugregulatory_credevo-1-1024x548.png\" alt=\"\" class=\"wp-image-1112 size-full\" srcset=\"https:\/\/credevo.com\/s\/wp-content\/uploads\/2020\/03\/rarediseaseregulatory_orphandrugregulatory_credevo-1-1024x548.png 1024w, https:\/\/credevo.com\/s\/wp-content\/uploads\/2020\/03\/rarediseaseregulatory_orphandrugregulatory_credevo-1-300x161.png 300w, https:\/\/credevo.com\/s\/wp-content\/uploads\/2020\/03\/rarediseaseregulatory_orphandrugregulatory_credevo-1-768x411.png 768w, https:\/\/credevo.com\/s\/wp-content\/uploads\/2020\/03\/rarediseaseregulatory_orphandrugregulatory_credevo-1-600x320.png 600w, https:\/\/credevo.com\/s\/wp-content\/uploads\/2020\/03\/rarediseaseregulatory_orphandrugregulatory_credevo-1.png 1920w\" sizes=\"auto, (max-width: 1024px) 100vw, 1024px\" \/><\/figure><div class=\"wp-block-media-text__content\">\n<p>Yes, drug development in rare diseases, unlike traditional drugs, involves special considerations and regulatory approaches such as financial benefits, faster approvals, and less stringent clinical data requirements. <\/p>\n\n\n\n<p>We understand various regulatory approaches with our regulatory expertise and practical knowledge in obtaining orphan drug designation and market approvals. <\/p>\n<\/div><\/div>\n\n\n\n<div style=\"height:20px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<hr class=\"wp-block-separator\"\/>\n\n\n\n<div style=\"height:20px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<blockquote class=\"wp-block-quote is-layout-flow wp-block-quote-is-layout-flow\"><p>Learn more on various regulators providing incentives in rare disease drug development<\/p><\/blockquote>\n\n\n\n<blockquote class=\"wp-block-quote is-layout-flow wp-block-quote-is-layout-flow\"><p><a href=\"https:\/\/credevo.com\/articles\/2019\/12\/15\/rare-diseases-regulatory-incentives-for-development-of-orphan-drugs-us-europe\/\">Rare disease regulatory incentives in United States &amp; Europe<\/a><\/p><p><a href=\"https:\/\/credevo.com\/articles\/2019\/12\/15\/rare-diseases-regulatory-incentives-for-development-of-orphan-drugs-us-europe\/\">Rare disease regulatory incentives in Japan &amp; Australia<\/a><\/p><p><a href=\"https:\/\/credevo.com\/articles\/2020\/02\/15\/rare-diseases-regulatory-incentives-for-development-of-orphan-drugs-china-india-russia-south-korea\/\">Rare disease regulatory incentives in Asian countries<\/a> <\/p><\/blockquote>\n\n\n\n<hr class=\"wp-block-separator\"\/>\n\n\n\n<div style=\"height:20px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<h2 class=\"has-text-align-center wp-block-heading\">What services does Credevo provide? <\/h2>\n\n\n\n<div style=\"height:20px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<div class=\"wp-block-media-text alignwide is-stacked-on-mobile\"><figure class=\"wp-block-media-text__media\"><img loading=\"lazy\" decoding=\"async\" width=\"1024\" height=\"548\" src=\"https:\/\/credevo.com\/s\/wp-content\/uploads\/2020\/03\/Otherservices_rarediseaseregulatory_orphandrugregulatory_credevo-1024x548.png\" alt=\"\" class=\"wp-image-1101 size-full\" srcset=\"https:\/\/credevo.com\/s\/wp-content\/uploads\/2020\/03\/Otherservices_rarediseaseregulatory_orphandrugregulatory_credevo-1024x548.png 1024w, https:\/\/credevo.com\/s\/wp-content\/uploads\/2020\/03\/Otherservices_rarediseaseregulatory_orphandrugregulatory_credevo-300x161.png 300w, https:\/\/credevo.com\/s\/wp-content\/uploads\/2020\/03\/Otherservices_rarediseaseregulatory_orphandrugregulatory_credevo-768x411.png 768w, https:\/\/credevo.com\/s\/wp-content\/uploads\/2020\/03\/Otherservices_rarediseaseregulatory_orphandrugregulatory_credevo-600x320.png 600w, https:\/\/credevo.com\/s\/wp-content\/uploads\/2020\/03\/Otherservices_rarediseaseregulatory_orphandrugregulatory_credevo.png 1920w\" sizes=\"auto, (max-width: 1024px) 100vw, 1024px\" \/><\/figure><div class=\"wp-block-media-text__content\">\n<p>Credevo offers all type of services right from preclinical to market approvals of Orphan drugs in rare diseases.<\/p>\n\n\n\n<ul class=\"wp-block-list\"><li>Pre-clinical &amp; Clinical regulatory services<\/li><li>Dossier compilation guidance, submissions<\/li><li>Marketing authorization guidance<\/li><\/ul>\n<\/div><\/div>\n\n\n\n<div style=\"height:20px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<h2 class=\"has-text-align-center wp-block-heading\">In which countries does Credevo provide the regulatory service for rare diseases?<\/h2>\n\n\n\n<div style=\"height:20px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<div class=\"wp-block-media-text alignwide has-media-on-the-right is-stacked-on-mobile\"><figure class=\"wp-block-media-text__media\"><img loading=\"lazy\" decoding=\"async\" width=\"1024\" height=\"548\" src=\"https:\/\/credevo.com\/s\/wp-content\/uploads\/2020\/03\/countries_regulatoryservices_orphandrug_regulatory_credevo-1024x548.png\" alt=\"\" class=\"wp-image-1104 size-full\" srcset=\"https:\/\/credevo.com\/s\/wp-content\/uploads\/2020\/03\/countries_regulatoryservices_orphandrug_regulatory_credevo-1024x548.png 1024w, https:\/\/credevo.com\/s\/wp-content\/uploads\/2020\/03\/countries_regulatoryservices_orphandrug_regulatory_credevo-300x161.png 300w, https:\/\/credevo.com\/s\/wp-content\/uploads\/2020\/03\/countries_regulatoryservices_orphandrug_regulatory_credevo-768x411.png 768w, https:\/\/credevo.com\/s\/wp-content\/uploads\/2020\/03\/countries_regulatoryservices_orphandrug_regulatory_credevo-600x320.png 600w, https:\/\/credevo.com\/s\/wp-content\/uploads\/2020\/03\/countries_regulatoryservices_orphandrug_regulatory_credevo.png 1920w\" sizes=\"auto, (max-width: 1024px) 100vw, 1024px\" \/><\/figure><div class=\"wp-block-media-text__content\">\n<p>Developing drugs for rare diseases is financially not viable unless the drug or medical device receives an orphan drug designation and regulatory incentives. <\/p>\n\n\n\n<p>Choosing a country that supports rare disease drug development is advisable, and Credevo provides regulatory services in countries that are feasible and support rare disease drug development. <\/p>\n<\/div><\/div>\n\n\n\n<div style=\"height:20px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<h2 class=\"has-text-align-center wp-block-heading\">What are the other services other than regulatory does Credevo provide?<\/h2>\n\n\n\n<div style=\"height:20px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<div class=\"wp-block-media-text alignwide is-stacked-on-mobile\"><figure class=\"wp-block-media-text__media\"><img loading=\"lazy\" decoding=\"async\" width=\"1024\" height=\"576\" src=\"https:\/\/credevo.com\/s\/wp-content\/uploads\/2020\/03\/services_clinicaltrialfeasibility_clinicalinvestigator_credevo-1024x576.png\" alt=\"\" class=\"wp-image-1056 size-full\" srcset=\"https:\/\/credevo.com\/s\/wp-content\/uploads\/2020\/03\/services_clinicaltrialfeasibility_clinicalinvestigator_credevo-1024x576.png 1024w, https:\/\/credevo.com\/s\/wp-content\/uploads\/2020\/03\/services_clinicaltrialfeasibility_clinicalinvestigator_credevo-300x169.png 300w, https:\/\/credevo.com\/s\/wp-content\/uploads\/2020\/03\/services_clinicaltrialfeasibility_clinicalinvestigator_credevo-768x432.png 768w, https:\/\/credevo.com\/s\/wp-content\/uploads\/2020\/03\/services_clinicaltrialfeasibility_clinicalinvestigator_credevo.png 1920w\" sizes=\"auto, (max-width: 1024px) 100vw, 1024px\" \/><\/figure><div class=\"wp-block-media-text__content\">\n<p>We also provide services other than regulation in rare disease drug development such as<\/p>\n\n\n\n<ul class=\"wp-block-list\"><li>Comparator shipment<\/li><li>Special rare disease clinical trial feasibility services<\/li><li>Clinical trial monitoring services<\/li><li>Find clinical investigators for your rare disease orphan drug trials<\/li><\/ul>\n<\/div><\/div>\n\n\n\n<div style=\"height:20px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<hr class=\"wp-block-separator\"\/>\n\n\n\n<blockquote class=\"wp-block-quote has-text-align-center is-style-large is-layout-flow wp-block-quote-is-layout-flow\"><p>For queries, contact us at <a href=\"mailto:inquiry@credevo.com\">inquiry@credevo.com<\/a><\/p><\/blockquote>\n\n\n\n<hr class=\"wp-block-separator\"\/>\n\n\n\n<div style=\"height:20px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Is regulatory for orphan drugs in rare diseases different from traditional drugs? Yes, drug development in rare diseases, unlike traditional drugs, involves special considerations and regulatory approaches such as financial benefits, faster approvals, and less stringent clinical data requirements. We understand various regulatory approaches with our regulatory expertise and practical knowledge in obtaining orphan drug [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":1170,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"footnotes":""},"class_list":["post-1083","page","type-page","status-publish","has-post-thumbnail","hentry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v25.3.1 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Regulatory Services - Credevo<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/credevo.com\/s\/rare-diseases-regulatory-service\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Regulatory Services - Credevo\" \/>\n<meta property=\"og:description\" content=\"Is regulatory for orphan drugs in rare diseases different from traditional drugs? Yes, drug development in rare diseases, unlike traditional drugs, involves special considerations and regulatory approaches such as financial benefits, faster approvals, and less stringent clinical data requirements. We understand various regulatory approaches with our regulatory expertise and practical knowledge in obtaining orphan drug [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/credevo.com\/s\/rare-diseases-regulatory-service\/\" \/>\n<meta property=\"og:site_name\" content=\"Credevo\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/credevo\" \/>\n<meta property=\"article:modified_time\" content=\"2023-08-04T09:14:37+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/credevo.com\/s\/wp-content\/uploads\/2020\/03\/clinicaltrialregulatory_service_raredisease_orphandrugs_credevo.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1920\" \/>\n\t<meta property=\"og:image:height\" content=\"671\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:site\" content=\"@gocredevo\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/credevo.com\/s\/rare-diseases-regulatory-service\/\",\"url\":\"https:\/\/credevo.com\/s\/rare-diseases-regulatory-service\/\",\"name\":\"Regulatory Services - Credevo\",\"isPartOf\":{\"@id\":\"https:\/\/credevo.com\/s\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/credevo.com\/s\/rare-diseases-regulatory-service\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/credevo.com\/s\/rare-diseases-regulatory-service\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/credevo.com\/s\/wp-content\/uploads\/2020\/03\/clinicaltrialregulatory_service_raredisease_orphandrugs_credevo.png\",\"datePublished\":\"2019-08-16T06:50:45+00:00\",\"dateModified\":\"2023-08-04T09:14:37+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/credevo.com\/s\/rare-diseases-regulatory-service\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/credevo.com\/s\/rare-diseases-regulatory-service\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/credevo.com\/s\/rare-diseases-regulatory-service\/#primaryimage\",\"url\":\"https:\/\/credevo.com\/s\/wp-content\/uploads\/2020\/03\/clinicaltrialregulatory_service_raredisease_orphandrugs_credevo.png\",\"contentUrl\":\"https:\/\/credevo.com\/s\/wp-content\/uploads\/2020\/03\/clinicaltrialregulatory_service_raredisease_orphandrugs_credevo.png\",\"width\":1920,\"height\":671},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/credevo.com\/s\/rare-diseases-regulatory-service\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Services\",\"item\":\"https:\/\/credevo.com\/s\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Regulatory Services\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/credevo.com\/s\/#website\",\"url\":\"https:\/\/credevo.com\/s\/\",\"name\":\"Credevo\",\"description\":\"Healthcare Product Development from Clinical Development to Commercialization\",\"publisher\":{\"@id\":\"https:\/\/credevo.com\/s\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/credevo.com\/s\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/credevo.com\/s\/#organization\",\"name\":\"Credevo Pte. Ltd.\",\"url\":\"https:\/\/credevo.com\/s\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/credevo.com\/s\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/credevo.com\/s\/wp-content\/uploads\/2021\/02\/logo_bw2_old.png\",\"contentUrl\":\"https:\/\/credevo.com\/s\/wp-content\/uploads\/2021\/02\/logo_bw2_old.png\",\"width\":160,\"height\":160,\"caption\":\"Credevo Pte. Ltd.\"},\"image\":{\"@id\":\"https:\/\/credevo.com\/s\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/credevo\",\"https:\/\/x.com\/gocredevo\",\"https:\/\/www.instagram.com\/credevo_official\/\",\"https:\/\/www.linkedin.com\/company\/credevo\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Regulatory Services - Credevo","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/credevo.com\/s\/rare-diseases-regulatory-service\/","og_locale":"en_US","og_type":"article","og_title":"Regulatory Services - Credevo","og_description":"Is regulatory for orphan drugs in rare diseases different from traditional drugs? Yes, drug development in rare diseases, unlike traditional drugs, involves special considerations and regulatory approaches such as financial benefits, faster approvals, and less stringent clinical data requirements. We understand various regulatory approaches with our regulatory expertise and practical knowledge in obtaining orphan drug [&hellip;]","og_url":"https:\/\/credevo.com\/s\/rare-diseases-regulatory-service\/","og_site_name":"Credevo","article_publisher":"https:\/\/www.facebook.com\/credevo","article_modified_time":"2023-08-04T09:14:37+00:00","og_image":[{"width":1920,"height":671,"url":"https:\/\/credevo.com\/s\/wp-content\/uploads\/2020\/03\/clinicaltrialregulatory_service_raredisease_orphandrugs_credevo.png","type":"image\/png"}],"twitter_card":"summary_large_image","twitter_site":"@gocredevo","twitter_misc":{"Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/credevo.com\/s\/rare-diseases-regulatory-service\/","url":"https:\/\/credevo.com\/s\/rare-diseases-regulatory-service\/","name":"Regulatory Services - Credevo","isPartOf":{"@id":"https:\/\/credevo.com\/s\/#website"},"primaryImageOfPage":{"@id":"https:\/\/credevo.com\/s\/rare-diseases-regulatory-service\/#primaryimage"},"image":{"@id":"https:\/\/credevo.com\/s\/rare-diseases-regulatory-service\/#primaryimage"},"thumbnailUrl":"https:\/\/credevo.com\/s\/wp-content\/uploads\/2020\/03\/clinicaltrialregulatory_service_raredisease_orphandrugs_credevo.png","datePublished":"2019-08-16T06:50:45+00:00","dateModified":"2023-08-04T09:14:37+00:00","breadcrumb":{"@id":"https:\/\/credevo.com\/s\/rare-diseases-regulatory-service\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/credevo.com\/s\/rare-diseases-regulatory-service\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/credevo.com\/s\/rare-diseases-regulatory-service\/#primaryimage","url":"https:\/\/credevo.com\/s\/wp-content\/uploads\/2020\/03\/clinicaltrialregulatory_service_raredisease_orphandrugs_credevo.png","contentUrl":"https:\/\/credevo.com\/s\/wp-content\/uploads\/2020\/03\/clinicaltrialregulatory_service_raredisease_orphandrugs_credevo.png","width":1920,"height":671},{"@type":"BreadcrumbList","@id":"https:\/\/credevo.com\/s\/rare-diseases-regulatory-service\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Services","item":"https:\/\/credevo.com\/s\/"},{"@type":"ListItem","position":2,"name":"Regulatory Services"}]},{"@type":"WebSite","@id":"https:\/\/credevo.com\/s\/#website","url":"https:\/\/credevo.com\/s\/","name":"Credevo","description":"Healthcare Product Development from Clinical Development to Commercialization","publisher":{"@id":"https:\/\/credevo.com\/s\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/credevo.com\/s\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/credevo.com\/s\/#organization","name":"Credevo Pte. Ltd.","url":"https:\/\/credevo.com\/s\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/credevo.com\/s\/#\/schema\/logo\/image\/","url":"https:\/\/credevo.com\/s\/wp-content\/uploads\/2021\/02\/logo_bw2_old.png","contentUrl":"https:\/\/credevo.com\/s\/wp-content\/uploads\/2021\/02\/logo_bw2_old.png","width":160,"height":160,"caption":"Credevo Pte. Ltd."},"image":{"@id":"https:\/\/credevo.com\/s\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/credevo","https:\/\/x.com\/gocredevo","https:\/\/www.instagram.com\/credevo_official\/","https:\/\/www.linkedin.com\/company\/credevo"]}]}},"_links":{"self":[{"href":"https:\/\/credevo.com\/s\/wp-json\/wp\/v2\/pages\/1083","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/credevo.com\/s\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/credevo.com\/s\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/credevo.com\/s\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/credevo.com\/s\/wp-json\/wp\/v2\/comments?post=1083"}],"version-history":[{"count":23,"href":"https:\/\/credevo.com\/s\/wp-json\/wp\/v2\/pages\/1083\/revisions"}],"predecessor-version":[{"id":4360,"href":"https:\/\/credevo.com\/s\/wp-json\/wp\/v2\/pages\/1083\/revisions\/4360"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/credevo.com\/s\/wp-json\/wp\/v2\/media\/1170"}],"wp:attachment":[{"href":"https:\/\/credevo.com\/s\/wp-json\/wp\/v2\/media?parent=1083"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}